|Bid||186.00 x 800|
|Ask||195.50 x 1000|
|Day's Range||188.42 - 194.46|
|52 Week Range||173.45 - 431.11|
|Beta (5Y Monthly)||1.10|
|PE Ratio (TTM)||44.48|
|Earnings Date||Apr 25, 2022 - Apr 29, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||296.75|
Illumina (ILMN) closed at $190.38 in the latest trading session, marking a -1.61% move from the prior day.
The European Society of Medical Oncology (ESMO) annual congress convened earlier this month in Paris, where, Illumina presented key abstracts demonstrating the clinical utility of comprehensive genomic profiling (CGP).
US nonprofit GRID Alternatives launches new projects to provide renewable energy